Robert L. Challender Joins MDS Pharma Services as VP Finance - Late Stage Development at its King of Prussia Executive Offices
17 Settembre 2004 - 4:00PM
PR Newswire (US)
Robert L. Challender Joins MDS Pharma Services as VP Finance - Late
Stage Development at its King of Prussia Executive Offices
MONTREAL, Sept. 17 /PRNewswire-FirstCall/ -- MDS Pharma Services, a
leading provider of innovative drug discovery and development
solutions, has hired Robert L. Challender as vice president for
Finance - Late Stage Development, effective September 1, 2004.
Based in the MDS Pharma Services executive offices in King of
Prussia, Pa., Challender brings additional strength and depth to
the global Finance team. "Bob has established a solid record of
developing and executing income enhancing strategies and cost
management initiatives," says Alan Horgan, group Vice President.
"He has 15 years of experience in all areas of finance and
accounting, and a decade of experience in our industry." Prior to
joining MDS Pharma Services, Challender served five years as CFO
for the global Clinical Development Services division of Covance,
Inc. in Princeton, N.J. He played a key role in reorganizing the
division's three regional operating groups into one internationally
managed operation. In addition, Challender managed several
non-finance related functions during his tenure at Covance,
including the Contract Management, Real Estate and Facilities, and
the Proposal Development departments. He holds an MBA and BA in
Computer Science from Rutgers University. MDS Pharma Services
offers a full spectrum of resources to meet the drug discovery and
development needs of the pharmaceutical and biotechnology
industries. With numerous facilities strategically located around
the world, the company applies advanced scientific and
technological expertise to each stage of the drug discovery and
development process - early stage: lead optimization, pre-IND
research, pharmaceutical and biopharmaceutical development, early
clinical research (bioequivalence, phases I-IIa) and bioanalysis;
and late stage: global clinical development (phases IIb-IV) and
central lab. For more information, visit MDS Pharma Services' Web
site at http://www.mdsps.com/. MDS Pharma Services is part of MDS
Inc. (TSX: MDS; NYSE: MDZ), an international health and life
sciences company. At MDS Inc., our 10,000 highly skilled people
provide services, products and instruments enabling health sciences
organizations to enhance the well being of people around the world.
We focus on helping discover and test new drugs, assisting doctors
to diagnose and treat patients and preventing the spread of
disease. Find out more about MDS Inc. (TSX: MDS; NYSE: MDZ), at
http://www.mdsintl.com/ or by calling 1-888-MDS-7222, 24 hours a
day. DATASOURCE: MDS Pharma Services; MDS Inc. CONTACT: or to
receive a high-resolution photograph of Robert L. Chandler suitable
for print reproduction, please contact Charlene McGrady, MDS Pharma
Services, 2200 Renaissance Boulevard, King of Prussia, Penn., Tel:
(610) 239-7900, ext. 231, and visit our Web site at
http://www.mdsps.com/
Copyright